Yahoo Web Search

Search results

1. • 

     Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today

     Investor's Business Daily· 2 years ago

     A gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...

2. • 

     Advanced Esophageal Cancer and Immunotherapy

     Verywell Health via Yahoo News· 9 months ago

     A Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...

3. • 

     'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...

     USA TODAY via Yahoo News· 2 years ago

     Patients with advanced lung cancer had a better chance at survival when their treatment combined...

4. • 

     Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

     Investor's Business Daily· 1 year ago

     Moderna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...

5. • 

     Jemperli contends with blockbuster Keytruda in endometrial cancer

     Clinical Trials Arena via Yahoo Finance· 2 weeks ago

     On April 24, the FDA granted Priority Review to the supplemental Biologics License Application...

6. • 

     How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks

     Investor's Business Daily· 7 months ago

     More than two-thirds of patients responded to an experimental bladder cancer treatment from Merck...

7. • 

     Merck stops testing combo drug for skin cancer as more patients discontinue

     Reuters via Yahoo News· 4 days ago

     This is the latest setback for the experimental drug, vibostolimab, and the related promising new...

8. • 

     The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed

     Investor's Business Daily· 2 years ago

     Shares of MRTX stock rocketed Tuesday after Mirati Therapeutics unveiled early — but promising —...

9. • 

     BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...

     Investor's Business Daily· 11 months ago

     German biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...

10. • 

      Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat

      Investor's Business Daily· 3 weeks ago

      Merck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...